| Pharmaceutical active ingredients: |
| GlyburideMetformin Hydrochloride |
| Available forms, composition and doses of Diaglitab Plus: |
| Tablets; Oral; Glyburide 2.5 mg; Metformin Hydrochloride 500 mgTablets; Oral; Glyburide 5 mg; Metformin Hydrochloride 500 mg |
| Diaglitab Plus medical category: |
| Human:Antidiabetic agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A10BB01 - GlibenclamideA10BD02 - Metformin and sulfonamides |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Recalcine Laboratorios |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Dabex G | Glyburide; Metformin Hydrochloride | Merck |
| Daonil M | Glyburide; Metformin Hydrochloride | Sanofi-Aventis |
| Diabetrol | Glyburide; Metformin Hydrochloride | Abbott |
| Diabetyl G | Glyburide; Metformin Hydrochloride | Biotoscana Farma |
| Diaforte | Glyburide; Metformin Hydrochloride | Cipla |
| Diamide | Glyburide; Metformin Hydrochloride | Hovid |
| Diatrac-M | Glyburide; Metformin Hydrochloride | Invision Medi Sciences |
| Dimefor-G | Glyburide; Metformin Hydrochloride | Siegfried Rhein |
| Diofen | Glyburide; Metformin Hydrochloride | Liptis Pharmaceuticals |
| Diolin-M | Glyburide; Metformin Hydrochloride | Aristo Pharmaceuticals |